These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38844022)

  • 1. Comprehensive analysis of the functions, prognostic and diagnostic values of RNA binding proteins in head and neck squamous cell carcinoma.
    Liu H; Ye Z; Wang X; Wu Y; Deng C
    J Stomatol Oral Maxillofac Surg; 2024 Sep; 125(4S):101937. PubMed ID: 38844022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of the Roles and Prognostic Value of RNA-Binding Proteins in Head and Neck Squamous Cell Carcinoma.
    Jin Y; Qin X
    DNA Cell Biol; 2020 Oct; 39(10):1789-1798. PubMed ID: 32716650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a RNA binding protein-associated prognostic model for head and neck squamous cell carcinoma.
    Yang X; Han B; Zhang R; Su Y; Hosseini DK; Wu H; Yang M; Sun H
    Aging (Albany NY); 2021 Mar; 13(6):7975-7997. PubMed ID: 33758106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of seven RNA binding protein genes as a prognostic signature in oral cavity squamous cell carcinoma.
    Huang Z; Lan T; Wang J; Chen Z; Zhang X
    Bioengineered; 2021 Dec; 12(1):7248-7262. PubMed ID: 34585646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic analysis of the function and prognostic value of RNA binding protein in head and neck squamous cell carcinoma.
    Duan X; Cheng X; Yin X; Ke Z; Song J
    Eur Arch Otorhinolaryngol; 2022 Mar; 279(3):1535-1547. PubMed ID: 34218307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
    Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Chromatin Regulator-related Molecular Subtypes and a Signature to Predict Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma.
    Huang J; Xu Z; Wang Z; Zhou C; Shen Y
    Curr Cancer Drug Targets; 2024; 24(8):804-819. PubMed ID: 38310463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma.
    Mao R; Chen Y; Xiong L; Liu Y; Zhang T
    Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of glycosyltransferase related-gene for the diagnosis and prognosis of head and neck squamous cell carcinoma.
    He M; Wang L; Yue Z; Feng C; Dai G; Jiang J; Huang H; Ji Q; Zhou M; Li D; Chai W
    Aging (Albany NY); 2024 Jan; 16(2):1750-1766. PubMed ID: 38244579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.
    Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J
    BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated Analysis of the Functions and Prognostic Values of RNA Binding Proteins in Lung Squamous Cell Carcinoma.
    Li W; Li X; Gao LN; You CG
    Front Genet; 2020; 11():185. PubMed ID: 32194639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
    Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
    Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of AURKA as a Biomarker Associated with Cuproptosis and Ferroptosis in HNSCC.
    Jia X; Tian J; Fu Y; Wang Y; Yang Y; Zhang M; Yang C; Liu Y
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of immunogenic cell death-related damage-related molecular patterns (DAMPs) to predict outcomes in patients with head and neck squamous cell carcinoma.
    Zhang J; Shi X; Wang M; Zhai R; Wang M; Gong Z; Ni Z; Xu T; Zhu W; Liu L
    J Cancer Res Clin Oncol; 2024 May; 150(5):240. PubMed ID: 38713284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Potential of Oxidative Stress Related Genes as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma.
    Wang X; Zhou G
    Comb Chem High Throughput Screen; 2022; 25(11):1952-1965. PubMed ID: 34875987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H
    Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma.
    Jiang L; Yin X; Zhang H; Zhang X; Cao Z; Zhou M; Xu W
    Biomed Res Int; 2023; 2023():4444869. PubMed ID: 36814797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma.
    Wang J; Bian Q; Liu J; Moming A
    Bioengineered; 2021 Dec; 12(2):10049-10062. PubMed ID: 34872450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.